VectraCor Cuts to the Heart of Cardiac Symptoms
According to the American Heart Association, approximately 325,000 people per year die of a heart attack before they can reach a hospital.
Articles by vanderson
Oncology Drugs Experience Sales Slowdown In U.S.
Cancer drug sales are slowing down in the U.S., Reuters reported Monday.
Advanced Life Sciences Announces Two New Achievements
Advanced Life Sciences (OTC BB: ADLS) took two steps this week toward advancing its lead drug candidate, Restanza.
Cytori Therepeutics Featured in Wired Magazine
Wired magazine recently published a feature on Cytori Therapeutics, a regenerative medicine company based in San Diego that is using stem and regenerative stem cells derived from fat (adipose) tissue to repair breasts disfigured by mastectomies and lumpectomies.
AdvaMed 2010 a Success
More than 1,700 medical device and diagnostics leaders from more than 360 companies, representing 24 countries and 33 states, attended the fourth annual industry gathering, AdvaMed 2010: The MedTech Conference from Oct 18-20 in Washington, D.C.
GE Healthcare to Acquire Diagnostics Company Clarient
General Electric announced Friday that its healthcare unit will acquire molecular diagnostics company Clarient in a deal worth approximately $580 million.
Neurotez Developing Hormone Replacement Therapy for Alzheimer’s
Could the same hormone that regulates your appetite keep you from developing Alzheimer’s?
Ischemic Stroke: Challenging Market, Huge Need
Time is critical when a patient suffers from a stroke.
NeoVista’s Macular Degeneration Device Improves Visual Acuity in Yearlong Study
Medical device company NeoVista, Inc., recently announced 12-month results from its MERITAGE study in patients with wet age-related macular degeneration, a leading cause of vision loss in older Americans.